Geographic distribution of clinical trials for advanced-stage cancer

JAMA Oncology

2024-06-03

(Press-News.org) About The Study: This quality improvement analysis of clinical trials for metastatic breast, lung, colon, pancreatic, and prostate cancers found that a large proportion of the U.S. population lived within 30 miles of a clinical trial site. This finding suggests that while many clinical trials are available, they are not evenly distributed across the country and may not be accessible to all individuals, particularly racial and ethnic minority individuals. This disparity in access to clinical trials raises important questions about equity and fairness in the distribution of health care resources and opportunities for treatment.

Corresponding Author: To contact the corresponding author, Wade T. Swenson, M.D., M.P.H., M.B.A., email drswenson@lakewoodhealthsystem.com; wade@ruralcancer.org.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamaoncol.2024.1690)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Media advisory: This study is being presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2024.1690?guestAccessKey=6f68fd34-2884-4496-b5bf-5e2bc1ddde9f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=060324

END

ELSE PRESS RELEASES FROM THIS DATE:

PSU secures $1 million grant for high-performance computing cluster across Oregon

2024-06-03

Portland State will power up a new high-performance computing cluster that will give researchers at universities and colleges across Oregon the ability to advance computing-intensive research projects by processing large datasets and performing complex computations in a fraction of the time — thanks to a nearly $1 million grant from the National Science Foundation’s Campus Cyberinfrastructure program. The Oregon Regional Computing Accelerator (Orca) aims to provide free-of-cost computing resources and cyberinfrastructure ...

New $12.5 million National Science Foundation grant awarded to study phenomenon affecting agriculture, cancer, biodiversity and more

2024-06-03

It’s in your heart and liver, in the vegetables you eat, in the rogue cells that cause cancer. Those who live in temperate regions are surrounded by more of it than people who live in the tropics, and without it, humans wouldn’t exist. It’s called polyploidy, and only within the last few years have biologists begun to recognize its significance across the tree of life. “It’s one of the most important biological processes that hardly anybody knows about,” said Doug Soltis, a distinguished professor at the Florida Museum of Natural History. Soltis is one of 18 scientists who have received a combined ...

SwRI-led team to bolster earthquake readiness for U.S. Federal Highway Administration

2024-06-03

SAN ANTONIO — June 3, 2024 — Southwest Research Institute will enhance models to strengthen the earthquake resilience of America’s transportation infrastructure and improve public safety in earthquake-prone areas. As part of a contract with the U.S. Federal Highway Administration (FHWA), an SwRI-led team will update and improve liquefaction models. Liquefaction occurs during an earthquake when intense shaking causes soil to temporarily act more like a fluid, losing its capacity to support roads and structures. “For highways specifically, sometimes state and ...

Updating the way the Lab computes

2024-06-03

Unraveling the behavior of plasma increasingly requires intensive computing resources. That’s why plasma demands a calculated approach to computation. As the new head of computational sciences at the U.S. Department of Energy’s (DOE) Princeton Plasma Physics Laboratory (PPPL), Shantenu Jha is excited to be at the helm of the Lab’s computing efforts, fusing computer science expertise with PPPL’s pioneering research into the fourth state of matter. “I want to continue to grow the excellence that already exists in computing for fusion energy at PPPL, which ...

New study finds popular diabetes and weight-loss drugs associated with reduction in incidence and recurrence of alcohol-use disorder by at least half

2024-06-03

CLEVELAND—A new study by researchers at the Case Western Reserve University School of Medicine reveals that the popular diabetes and weight-loss drugs Wegovy and Ozempic are linked to reduced incidence and recurrence of alcohol abuse or dependence. The team’s findings, recently published in the journal Nature Communications, may suggest a possible new treatment for excessive alcohol use—including alcohol-use disorder (AUD), a health condition that causes about 178,000 deaths in the United States each year, according to the Centers for Disease Control. To date, the U.S. Food and Drug Administration (FDA) has approved only three medications to treat AUD. The active ingredient ...

Protein discovery could help prevent cancer treatment-related heart damage

2024-06-03

Blocking a protein known as CDK7 could prevent heart damage associated with a commonly used cancer chemotherapy medication, according to a study led by scientists at Washington State University. Importantly, the researchers also found that inhibiting CDK7 could help enhance the medication’s cancer-killing capability. Based on an animal model, the study findings could provide a foundation for future treatment strategies to reduce chemotherapy-related heart toxicity and increase treatment effectiveness. ...

Fewer than 1 in 4 patients receive dietary counseling after a heart attack

2024-06-03

Although diet is the leading contributor to premature death from heart disease in the United States, fewer than one-quarter of people who undergo major heart events receive dietary counseling in the aftermath, a study finds. The research, led by a team from the University of Michigan Health Frankel Cardiovascular Center, tracked nearly 150,000 patients seen at hospitals across Michigan for serious heart conditions — such as heart attack and heart failure — between late 2015 and early 2020. Results published in Journal of the Academy of Nutrition ...

Endocrine Society Guideline recommends healthy adults under the age of 75 take the recommended daily allowance of vitamin D

2024-06-03

BOSTON—Healthy adults under the age of 75 are unlikely to benefit from taking more than the daily intake of vitamin D recommended by the Institutes of Medicine (IOM) and do not require testing for vitamin D levels, according to a new Clinical Practice Guideline issued today by the Endocrine Society. For children, pregnant people, adults older than 75 years and adults with high-risk prediabetes, the guideline recommends vitamin D higher than the IOM recommended daily allowance. Vitamin D use and ...

A dark side to dark chocolate? New study finds very minimal risk for kids from metals in chocolates

2024-06-03

Chocolate lovers may have been alarmed by a 2023 Consumer Reports finding that some dark chocolate brands could contain harmful levels of lead and cadmium. However, a new study by Tulane University published in Food Research International has found that dark chocolate poses no adverse risk for adults and contains nutritionally beneficial levels of essential minerals. The study sampled 155 dark and milk chocolates from various global brands sold in the United States and tested for the presence of 16 heavy metals ranging from the toxic (lead and cadmium) to the essential (copper, iron, zinc). The study then modeled the risk of eating one ounce of the chocolates per day which ...

ECOG-ACRIN completes first trial of Black patients with early-stage breast cancer

2024-06-03

Black patients with early-stage breast cancer who were treated with docetaxel chemotherapy every 3 weeks had less drug-induced peripheral neuropathy and significantly fewer dose reductions compared to those who received weekly paclitaxel, according to a trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN). Study EAZ171 is the first National Cancer Institute (NCI)-sponsored trial to focus specifically on enrolling a minority or underserved population to assess drug-induced toxicity (rather than drug efficacy) ...

Geographic distribution of clinical trials for advanced-stage cancer

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: